We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
SELLAS Life Sciences Group Inc | NASDAQ:SLS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.02 | 1.65% | 1.23 | 1.23 | 1.25 | 1.28 | 1.13 | 1.16 | 1,104,224 | 00:59:27 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
001-33958
|
|
20-8099512
|
(State or other jurisdiction of incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
|
|
315 Madison Avenue, 4th Floor
New York, NY 10017
|
|
|
|
|
(Address of Principal Executive Offices) (Zip Code)
|
|
|
|
|
|
|
|
Registrant’s telephone number, including area code: (917) 438-4353
|
||||
|
|
|
|
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Exhibit
No.
|
|
Description
|
|
|
|
10.1
|
|
|
99.1
|
|
|
|
|
|
|
|
|
SELLAS Life Sciences Group, Inc.
|
||||
|
|
|
|
|
||||
Date:
|
|
May 2, 2018
|
|
|
|
By:
|
|
/s/ Angelos M. Stergiou
|
|
|
|
|
|
|
|
|
Angelos M. Stergiou, M.D., Sc.D.
President and Chief Executive Officer
|
1 Year SELLAS Life Sciences Chart |
1 Month SELLAS Life Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions